The pharma major in a filing on Tuesday said Valia will step down from the position of the company’s whole-time director to non-executive, non-independent director from May 29, 2019.
Sudhir Valia steps down from executive role at Sun Pharma
More from Industry NewsMore posts in Industry News »
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
- India initiates antidumping probe on certain type of steel from Brazil, China, Germany
- BDR Pharma receives DGCI nod for its generic drug BIAPENEM
- AstraZeneca invests in Imperial’s self-amplifying RNA technology with eye on future drugs